People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TaskEasy, Inc. | — | Other Technology | Series B | $41.3M | $64.8M | 2012 |
| Kythera Biopharmaceuticals Inc | — | Pharmaceuticals | Series B | $37.4M | $1.3B | 2011 |
| HavocAI Inc. | — | Other Technology | Series A | $12.2M | $61.8M | 2024 |
| Sequel Pharmaceuticals Inc | — | Pharmaceuticals | Seed | $5.4M | $38.0M | 2009 |
Joseph Turner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph Turner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Nina Kjellson | 1 | 11 |
| David Schnell | 1 | 7 |
| Jeff Davis | 1 | 7 |
| Camille Samuels | 1 | 6 |
| Paige Craig | 1 | 5 |
| David Lowe | 1 | 5 |
| Dennis Fenton | 1 | 4 |
| Stuart J.M. Collinson | 1 | 4 |
| Hironori Hozoji | 1 | 4 |
| Eckard Weber | 1 | 3 |
| Francois Kress | 1 | 3 |
| Keith Leonard | 1 | 3 |
| David Jensen | 1 | 3 |
| Nathaniel David | 1 | 3 |
| Richard P. Durham | 1 | 3 |
| Keith Klein | 1 | 2 |
| Daniel K. Turner, III | 1 | 2 |
| Jeff R. Davis | 1 | 2 |
| Howard C. Dittrich | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.